IP Library › Granted Patent US 11,078,527
Granted Patent B2
US 11,078,527 · App. 16/333,076 · Granted Aug 3, 2021

Method for quantifying and/or detecting human male DNA

Inventors: Miroslav Vranes (Hilden, DE); Ralf Peist (Hilden, DE); Mario Scherer (Hilden, DE); Stefan Otto Cornelius (Hilden, DE); Margaretha König (Hilden, DE)
Assignee: Qiagen GmbH
C12Q1/6827C12Q1/686C12Q1/6806C12Q1/6851C12Q1/6876C12Q1/6879C12Q2525/151C12Q2600/16C12Q2600/166
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,078,527
App. No.
16/333,076
Granted
Aug 3, 2021
Kind
B2
Abstract

According to a first aspect of the present invention, a method is provided for detecting and/or quantifying male genomic DNA in a sample, wherein the method comprises the step of amplification of a multicopy locus within the human Y-chromosome (MCL-Y), wherein said locus shares at least 80% sequence identity to a sequence according to SEQ ID NO. 3 over a stretch of at least 60 base pairs (bp). A second aspect of the present invention relates to a primer or primer pair which hybridizes under stringent conditions to a sequence according to SEQ ID NO. 3 and/or any of 4 to 11. The invention also relates to a kit.

Claims (25)

1. A method for detecting, assessing the status of and/or quantifying the fraction of male DNA in a sample, wherein the method comprises amplification of a multicopy locus within the Y-chromosome (MCL-Y), and wherein the amplification is performed using at least one primer selected from the group consisting of:

a. SEQ ID NO. 1;

b. SEQ ID NO. 2;

c. the reverse complement of SEQ ID NO. 1;

d. the reverse complement of SEQ ID NO. 2;

e. a primer that shares at least 90% sequence identity with SEQ ID NO. 1;

f. a primer that shares at least 90% sequence identity with SEQ ID NO. 2;

g. the reverse complement of a primer that shares at least 90% sequence identity with SEQ ID NO. 1; and

h. the reverse complement of a primer that shares at least 90% sequence identity with SEQ ID NO. 2.

2. The method according to claim 1 , wherein the amplification is performed using a primer pair selected from one of the groups consisting of:

a. SEQ ID NO. 1 and SEQ ID NO. 2;

b. the reverse complement of SEQ ID NO. 1 and the reverse complement of SEQ ID NO. 2;

c. a primer that shares at least 90% sequence identity with SEQ ID NO. 1 and a primer that shares at least 90% sequence identity with SEQ ID NO. 2; and

d. the reverse complement of a primer that shares at least 90% sequence identity with SEQ ID NO. 1 and the reverse complement of a primer that shares at least 90% sequence identity with SEQ ID NO. 2.

3. The method according to claim 1 , wherein the amplification step is performed using a primer pair having a sequence according to SEQ ID NO. 1 and SEQ ID NO. 2.

4. The method according to claim 1 , wherein said sample originates from whole blood, a blood fraction, an oral specimen, urine, human bioptic tissue or another part of a human body from which a genome is isolatable.

5. The method according to claim 1 , wherein said sample comprises male and female genomic DNA.

6. The method according to claim 1 , wherein the amplification step is performed by a polymerase chain reaction (PCR) or a real-time PCR reaction and the amount of nucleic acid determined is quantified either during the amplification process or as an end point measurement at the end of the amplification reaction.

7. The method according to claim 6 , wherein the amplification reaction comprises any one or more of:

a. Tris-HCl at a pH of between 8 and 8.8;

b. a potassium salt selected from the group of potassium chloride and potassium sulfate;

c. an ammonium salt;

d. magnesium chloride; and

e. a hot-start polymerase.

8. The method according to claim 6 , wherein the amplification reaction comprises amplifying at least two overlapping regions using at least one common primer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2019
From: VRANES, MIROSLAV; PEIST, RALF; SCHERER, MARIO; CORNELIUS, STEFAN OTTO; KÖNIG, MARGARETHA
To: QIAGEN GMBH
Reel/Frame 048587/0980 →
Priority Claims (1)
EP 16189210 · Sep 22, 2016 · regional
Continuity (1)
Related Publication 20190249233A1 · Aug 15, 2019